Clinical trials recruiting for Metastatic Castration-Resistant Prostate Carcinoma
7
Recruiting trials
24
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Lutetium Lu 177 Vipivotide Tetraxetan | 2 |
| (R)-9bMS | 1 |
| 18F-DCFPyL | 1 |
| Abemaciclib | 1 |
| Anti-STEAP1 CAR T-cells | 1 |
| Cyclophosphamide | 1 |
| Enzalutamide | 1 |
| Fludarabine | 1 |
| Lutetium Lu 177-PSMA-617 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 3 |
| Washington | 3 |
| Michigan | 2 |
| Wisconsin | 2 |
| Alaska | 1 |
| Colorado | 1 |
| Delaware | 1 |
| Georgia | 1 |
| Idaho | 1 |
| Illinois | 1 |
| Iowa | 1 |
| Massachusetts | 1 |
Top cities
Seattle, Washington 3Ann Arbor, Michigan 2San Francisco, California 2Ames, Iowa 1Anaconda, Montana 1Anchorage, Alaska 1Ankeny, Iowa 1Bakersfield, California 1Basking Ridge, New Jersey 1Battle Creek, Michigan 1
Self-screener
Recruiting trials
- Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
- Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
- Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
- Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
- SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
- Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Related conditions
Trials recruiting for Metastatic Castration-Resistant Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Prostate cancer 1234Stage IVB Prostate Cancer AJCC v8 27Metastatic Prostate Adenocarcinoma 13Metastatic Castration-resistant Prostate Cancer 67Stage IVA Prostate Cancer AJCC v8 13Stage IV Prostate Cancer AJCC v8 14Castration-Resistant Prostate Carcinoma 13
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Metastatic Castration-Resistant Prostate Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.